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dard” valuation method. The aim of this study is to review and
critique temporary health state valuation methods and identify
areas for future research. METHODS: We reviewed the literature
and evaluated preference-based temporary health state valuation
methods according to ﬁve criteria: (1) Consistency with quality-
adjusted life year theory; (2) Ease of use; (3) Relevance to tem-
porary health state-speciﬁc domains; (4) Sensitivity to health
state duration; and (5) Extent of bias. Our goal was to provide a
critical assessment of methods that could be used to obtain values
for use in cost-utility analyses. RESULTS: We identiﬁed six tem-
porary health state valuation methods. Methods modiﬁed stan-
dard approaches by prorating utilities, using a chained approach,
or trading-off waiting time or sleep instead of death in a time
trade-off. These modiﬁcations capture the effect of duration
better than standard methods. The strength of methods varied.
No method was well tested for validity and reliability with
respect to temporary health states. CONCLUSION: The litera-
ture on temporary health state valuation methods is sparse and
inadequate. Our critique did not identify a method that is appro-
priate for valuation of all temporary health states. Selection of
the most appropriate method should depend on the duration of
and type of temporary health state being considered. Further
research should focus on the validity, reliability and feasibility of
valuation under different circumstances. Utility values obtained
using temporary health state methods should be compared to
those using standard methods to quantify biases.
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OBJECTIVE: Measurement errors may be introduced in the
development, cultural adaptation, implementation, and analysis
of PRO assessments. Recent publications provide guidance to
minimize measurement errors during the development and cul-
tural adaptation stages. Very little guidance is available to
control errors, especially in multinational studies, introduced
during the implementation of PRO assessments. The objective of
this abstract is to highlight errors that may be introduced during
the implementation stage, speciﬁcally during the production of
data capture modules (e.g. Case Report Forms)for multi-national
studies. METHODS: A rigorous process was put in place to
monitor errors introduced during the CRF development process
with the aim of having a library of PRO instruments readily
available for use in clinical trials. After typesetting, CRF pages
were proof read by three independent reviewers including a
native speaker. Suspected errors including poor grammar and
typographical errors found in original PRO instruments were
reconciled with author’s permission and documented. RESULTS:
A total of 40 PRO instruments were used in 39 Phase III multi-
national studies involving 69 languages in 2006–2007. Three
instruments had multiple versions for the same language and the
author of another instrument did not have a list of available
translations. Two types of errors were found at the ﬁnal stage of
proof reading by native speakers. The ﬁrst, ambiguous or out-
dated terminology. The second, typesetting errors which may
have altered the meaning of the phrase or question. CONCLU-
SION: An adequate process must be in place to monitor, docu-
ment and minimize errors that may be introduced during the
implementation stage of PRO assessments. Failure to do so,
especially in multi-national studies, may invalidate the resources
spent during the development and translation stages and increase
the Company Risk.
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OBJECTIVES: The objective of the study is to derive an algo-
rithm to predict a cohort preference-based SF-6D index using the
eight mean health dimension scores when patient level data is
not available. METHODS: Health related quality of life data
(n = 6890) collected from patients with a wide range of health
conditions was used to explore the relationship between the
SF-6D and the eight dimension scores. Ordinary least square
regressions were derived using the eight dimension scores and
ﬁrst order interactions. Models were assessed for goodness of ﬁt
and predictive abilities using standard statistics such as variance
explained; residuals and the proportion of predicted values
within the minimal important difference. The models were also
compared on their abilities to predict mean cohort SF-6D scores
using mean dimension scores using both within-sample and
out-of sample published datasets. RESULTS: The OLS equations
obtained explained over 83% of the variance in the individual
SF-6D scores. While the models over-predict the lower health
states and under-predict the higher SF-6D scores on the indi-
vidual level, the mean absolute errors are in the region of 0.040.
When using mean dimension scores from within-sample sub-
groups and out-of sample published datasets, the majority of
predicted scores were well within the minimal important differ-
ence (0.041) for the SF-6D. The models are reasonably accurate
at predicting incremental values between study arms (mean error
0.012; mean absolute error 0.017) and when predicting incre-
mental changes over time (mean error 0.004; mean absolute
error 0.024). CONCLUSION: This paper presents a mechanism
to estimate a mean cohort preference-based SF-6D score from
published mean dimension scores. This study is unique in that it
uses published mean statistics to validate the results. The out-of
sample validation demonstrates the algorithms can be used to
inform both clinical and economic research. Further research is
required in different health conditions.
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OBJECTIVES: The objective of the study is to derive a method to
predict a cohort EQ-5D preference-based index score using pub-
lished statistics of the eight dimension scores describing the SF-36
health proﬁle. METHODS: Ordinary least square regressions are
used to obtain models from patient level data covering a wide
range of health conditions. The eight dimension scores, the
squares age and gender are used to derive a relationship with the
EQ-5D index. Models obtained are compared for goodness of ﬁt
using standard techniques such as descriptive statistics, variance
explained, the residuals and the proportion of values within the
minimal important difference. Predictive abilities are also com-
pared when using summary statistics from both within-sample
subgroups and datasets published studies. RESULTS: The models
obtained explain more than 56% of the variance in the EQ-5D
scores. For the individual predicted values, the mean predicted
EQ-5D score is correct to two decimal places and the mean
absolute error is approximately 0.13. Using summary statistics to
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predict within-sample subgroup mean EQ-5D scores, the mean
errors (mean absolute errors) range from 0.021 to 0.077 (0.045
to 0.083). When predicting baseline cohort EQ-5D scores using
published mean dimension scores the models produce mean
errors ranging from 0.048 to 0.099 with 76% of values correct to
within the minimal important difference. When predicting out-of
sample incremental differences between study arms and incre-
mental changes over time, over 71% of values are within the
minimal important difference. CONCLUSIONS: The models
provide researchers with a mechanism to estimate EQ-5D utility
data from published mean dimension scores. This research is
unique in that it uses mean statistics from published studies to
validate the results. While further research is required to validate
the results in additional health conditions, the algorithms can be
used to derive additional preference-based measures for use in
economic analyses.
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OBJECTIVE: Threshold of cost-effective analysis is thought to
be £20,000–£30,000 in UK and $50,000–$100,000 in the US,
however it is known that these values are not based on explicit
scientiﬁc evidence. We measured WTP for one additional QALY
gain to determine the threshold of cost-effectiveness analysis.
METHODS: We measured willingness to pay (WTP) for addi-
tional one year survival in perfect health status to determine
threshold of incremental cost-effectiveness ratio (ICER) by the
internet. The number of subjects is 1000 (500 male and 500
female in their 20 s to 50 s) in Japan, Republic of Korea (ROK),
Australia and UK. We asked them four kinds of WTP, i.e., 1)
WTP for their own additional QALY: (WTPsel); 2) WTP for their
own additional QALY 5 years later: (WTP5sel); 3) WTP for their
family’s additional one QALY: (WTPfam); and 4) the amount
they think society should pay for someone’s additional one
QALY: (WTPsoc). The double bound dichotomous choice was
applied to this research analyzed by nonparametric Turnbull
method. RESULTS: The value of WTPsel is ¥5 million (Japan),
ROK70 million Won, AUS$64,000 (Australia) and GBP23,000
(UK). Discount rate of outcome was calculated by comparing
WTPsel with WTP5sel, and it is estimated to be 6.8% (Japan),
3.7% (ROK), 1.9% (Australia) and 2.8% (UK). The order of
four kinds of WTP is WTP5sel < WTPsel < WTPsoc < WTPfam
in Japan and ROK, and WTP5sel < WTPsel < WTPfam <
WTPsoc in Australia and UK. CONCLUSION: Considering the
value of WTPfam (¥6.4 million), we think the threshold of ICER
should be determined to be ¥5 million to ¥6 million per QALY in
Japan. This result also shows the threshold and discount rate
adapted by NICE is reasonable. The difference of four WTP’s
order may represent cultural gap between Asia and Western
world.
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OBJECTIVE: To conduct a systematic review of studies that
employ conjoint analysis methodology in outcomes research in
medicine published between 1985 and 2006 in order to docu-
ment: i. clinical areas of focus; ii. sample size; iii. method of
design; iv. method of analysis and other quality parameters.
METHODS: Papers published between 1985 and 2006 were
identiﬁed on Medline, using the search terms conjoint analysis/
analyses, stated preference(s), discrete choice analysis/analyses,
and discrete choice modeling/experiments(s). All papers were
then reviewed for content by three reviewers, with papers not
actually related to conjoint analysis being deleted. Remaining
papers were then classiﬁed as: i. a clinical application; ii. an
application focusing on heath systems; or iii) papers focusing on
methods. We classiﬁed all clinical applications by ICD-9 codes
and identiﬁed key methodological characteristics such as sample
size, design methodology and type of analysis when available.
RESULTS: We began our review in 1985 due to the limited
number of publications between 1970 and 1985 (n = 4). Post
1985, 27% (n = 48) discussed the methodology of conjoint
analysis with no application, 25% (n = 45) focused on health
systems in medicine and 48% (n = 86) were clinical and thera-
peutic applications of conjoint analysis. There is a steady increase
in the use of conjoint in medicine between 1985 and 1999, most
common clinical areas being HIV, cancer and STI. The average
sample size is 267. Use of orthogonal arrays was the most
common design, 74% (n = 50) followed by adaptive conjoint
analysis, 16% (n = 11). Primary analysis techniques were probit
and logistic regression, 39% (n = 27) and 30% (n = 21) respec-
tively. CONCLUSIONS: We ﬁnd insufﬁcient information on
the methods used in a signiﬁcant proportion of manuscripts
reviewed. Given the importance of preference elicitation in medi-
cine, we need to focus on developing standardized research
practices for the application of conjoint analysis in outcomes
research.
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OBJECTIVE: Handheld computers and mobile phones allow
assessments of a variety of aspects of behaviour, experience and
performance in an everyday life setting. We have evaluated the
use of a mobile (cell) phone to collect data on alcohol consump-
tion, subjective state, and psychomotor performance and to
assess the relationships between these variables. METHODS:
Thirty eight healthy volunteers (20 male) aged 18–54 years
(mean 22.8) took part. The study program ran on any phone
supporting downloadable Java® applications. Text (SMS) mes-
sages were sent twice a day for 14 days according to a ran-
domised schedule, and volunteers completed their entries as soon
as possible after receiving the text. They recorded alcohol
consumption and mood, and completed performance tasks.
RESULTS: Compliance was good, with responses being made to
over 80% of text messages. Subjective drowsiness (% of visual
analogue scale length) ranged from 35.7–42.9 between 09:00
and 19:00 and from 51.5–57.7 between 21:00 and 01:00. Mean
ratings of drunkenness assessed between 21:00 and 01:00 were
5.5% (S.D. 12.2) where no alcohol consumption was recorded
and 53.1% (S.D. 21.0) where ﬁve or more drinks had been
consumed in the last six hours (ANOVA p < 0.001). Mean errors
on a memory scanning task were 6.6 (S.D. 4.7) with no alcohol
and 10.5 (S.D. 6.8) after 6 or more drinks (ANOVA p < 0.01).
CONCLUSION: Both objective and subjective measures showed
the expected relationship with reported alcohol consumption.
The widespread use of mobile phones means that this type of
study can be carried out economically and with reasonable train-
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